 The purpose of this trial is to test the combination of Gleevec also known as imatinib mesylate and Taxotere also known as docetaxel in patients with incurable stomach cancer. Gleevec is a pill form of chemotherapy and is indicated for the treatment of adult patients with chronic myeloid leukemia CML and gastrointestinal stromal tumors GIST. It is considered experimental for the treatment of stomach cancer. Taxotere docetaxel is a chemotherapy which is injected into the vein. It is approved for breast and lung cancer but has been shown to shrink many different types of tumors. Taxotere has been shown to shrink stomach cancer in about 20 - 30 of patients treated with Taxotere only. This study is being performed to see if the combination of Gleevec and Taxotere is an effective treatment for incurable stomach cancer with minimal side effects. 